Cancer Blog
- Dr. Robert Nagourney -

Here in 2023, we suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.

There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.

One noteworthy case was a 78-year-old patient successfully treated without surgery.

Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.

Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.

The battle against Stage IV pancreatic cancer is every bit as challenging as a hard fought military campaign.

Gastric (stomach) cancer is the fourth most common cancer worldwide with more than 930,000 diagnoses and 800,000 deaths attributed to...

I recently had an interesting conversation with a physician regarding her patient with an aggressive breast cancer. A portion of tumor...

The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...

The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...

The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...

I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...